Questions 1–11 (general knowledge questions) |
Q1: The WHO-NHLBI definition of bronchial asthma. |
Q2: Factors that are correlated to an increase in the incidence of the disease. |
Q3,Q4:Risk factors for the development of bronchial asthma. |
Q5,Q10: Factors that trigger an asthma attack. |
Q6: Elements from the clinical history that are useful for formulating the diagnosis |
of bronchial asthma. |
Q7: Laboratory – physiologic tests used for the diagnosis of the disease. |
Q8: Estimation of the severity of an asthma attack by clinical signs and laboratory |
test results. |
Q9: Differential diagnosis of bronchial asthma. |
Q11: Diurnal Peak Expiratory Flow (PEF) variation in the diagnosis of asthma. |
Questions 12–20 ("attitudes questions") |
Q12: Staging chronic asthma according to the severity and frequency of symptoms |
and to the PEF results. (Clinical cases). |
Q13: Pharmacological treatment of an imaginary patient with stage II bronchial |
asthma. (Clinical case). |
Q14: Pharmacological treatment of an imaginary patient with stage III bronchial |
asthma. (Clinical case). |
Q15: Management of bronchial asthma during pregnancy. Q16: Recognition of the stage and medicament choice for an imaginary patient with |
stage III bronchial asthma. (Clinical case). |
Q17: Management of chronic nocturnal cough in asthmatic patients. |
Q18: Alarming clinical signs during an acute asthma attack that compel an urgent |
referral of a patient to the hospital. |
Q19: Use of the inhaled corticosteroids in the management of chronic versus acute |
bronchial asthma. |
Q20: Instructions for the patients: When should they seek immediate medical care. |